Searchable abstracts of presentations at key conferences in endocrinology

ea0019p145 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Autocrine/paracrine regulation of visfatin induced MCP-1: enhanced pro-angiogeneic effects of visfatin in the human endothelium

Adya Raghu , Tan Bee , Chen Jing , Randeva Harpal

Objectives: Visfatin and monocyte-chemoattractant-protein-1 (MCP-1) are elevated in cardiovascular pathologies, insulin-resistant and dysmetabolic states. Visfatin has been reported to exhibit pro-angiogenic actions in human endothelial cells by the induction of endothelial gelatinases and VEGF. Given MCP-1’s well described pro-angiogenic properties we sought to study the potential interaction between visfatin, MCP-1 and VEGF in human endothelial cells. More importantly, ...

ea0016oc6.3 | Metabolism and cardiovascular | ECE2008

Visfatin induces MMP-2/9 activation in human vascular endothelial cells via nuclear factor-κB

Adya Raghu , Tan Bee , Chen Jing , Randeva Harpal

Aim: Cardiovascular disease is more common in individuals with diabetes mellitus and obesity. Visfatin is elevated in obesity and T2DM; and thought to be an inflammatory mediator within atherosclerotic lesions inducing gelatinase activity, contributing to plaque destabilisation. We investigated the activation of NF-κB, a well-known pro-inflammatory transcription factor, by visfatin, in Human Endothelial Cells (EC).Research design and methods: We sta...

ea0050oc2.6 | Clinical Highlights | SFEBES2017

Reduced early GLP-1 response in gestational diabetes is associated with hyperinsulinaemia and insulin resistance: a prospective case-control study

Sukumar Nithya , Bagias Christos , Goljan Ilona , Gharanei Seley , Tan Bee , Juls Holst Jens , Sa Ponnusamy

Background: Glucagon-like peptide-1 (GLP-1) concentrations are reduced by 20–50% in type 2 diabetes but studies in women with gestational diabetes mellitus (GDM) are inconclusive. Our aim was to study the GLP-1 profile during a glucose tolerance test (GTT) at GDM diagnosis and its relationship with insulin levels.Methods: A prospective study of selectively screened women was conducted. Plasma GLP-1, insulin and glucose were measured at 30-minute int...

ea0050oc2.6 | Clinical Highlights | SFEBES2017

Reduced early GLP-1 response in gestational diabetes is associated with hyperinsulinaemia and insulin resistance: a prospective case-control study

Sukumar Nithya , Bagias Christos , Goljan Ilona , Gharanei Seley , Tan Bee , Juls Holst Jens , Sa Ponnusamy

Background: Glucagon-like peptide-1 (GLP-1) concentrations are reduced by 20–50% in type 2 diabetes but studies in women with gestational diabetes mellitus (GDM) are inconclusive. Our aim was to study the GLP-1 profile during a glucose tolerance test (GTT) at GDM diagnosis and its relationship with insulin levels.Methods: A prospective study of selectively screened women was conducted. Plasma GLP-1, insulin and glucose were measured at 30-minute int...

ea0034p263 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Renalase a key regulator of brown adipose tissue activity

Ramanjaneya Manjunath , Tan Bee , Patel Vanlata , Hu Jiamiao , Lehnert Hendrik , Hillhouse Edward , Chen Jing , Randeva Harpal

Renalase is a recently discovered flavin adenine dinucleotide (FAD)-dependent oxidase, predominantly secreted into the circulation from the kidney and regulates catecholamine degradation and metabolism. Renalase gene is also present in heart muscle, skeletal muscle and liver cells in humans, and in mouse testicles. Four isoforms of renalase gene has been identified in humans (hRenalase1 to hRenalase4), however only hRenalase1 is detected in human blood suggesting that hRenalas...

ea0028p167 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2012

The Hepatokine Fetuin-A is increased in PCOS women. Association with metabolic syndrome and regulation by metformin

Aghilla Mohamed , Adya Raghu , Tan Bee , Lehnert Hendrik , Ashawesh Khaled , Randeva Harpal

Introduction: Polycystic Ovary Syndrome (PCOS) is associated with insulin resistance, visceral obesity -metabolic syndrome (MS) and non-alcoholic fatty liver disease (NAFLD). Fetuin-A, human protein: α2-Heremans-Schmid glycoprotein is an abundant serum protein exclusively expressed in the liver and has been suggested to act as a link between obesity, insulin resistance (IR), and MS.Aims: A) To determine levels of Fetuin-A in PCOS women. B) To invest...

ea0021p132 | Diabetes and metabolism | SFEBES2009

Positive correlation between serum omentin and thrombospondin-1 in gestational diabetes despite lack of correlation with insulin resistance indices

Lewandowski Krzysztof , Cypryk Katarzyna , Nadel Iwona , Lewinski Andrzej , Bienkiewicz Malgorzata , Tan Bee , Randeva Harpal

Background: Gestational diabetes (GDM) is characterized by insulin resistance and a pro-inflammatory state, both factors possible related to adipokine expression. In our study we have endeavoured to assess serum levels of insulin-sensitising omentin and pro-inflammatory thrombospondin-1 (TSP-1) in GDM.Subjects and methods: The study included 20 women with GDM, diagnosed according to the WHO criteria, age 29.7±5.5 (mean±S.D.), BMI...

ea0019oc7 | Young Endocrinologist prize session | SFEBES2009

In vivo and ex vivo regulation of Visfatin production by leptin in human and murine adipose tissue: role of the PI3K and MAPK pathways

Tan Bee , Chen Jing , Brown James , Adya Raghu , Ramanjaneya Manjunath , Bailey Cliff , Lehnert Hendrik , Randeva Harpal

Apart from its role in energy storage, adipose tissue produces several hormones and cytokines termed ‘adipokines’ that have wide-ranging effects on carbohydrate and lipid metabolism; and thereby, play an important role in the pathogenesis of the metabolic syndrome. Visfatin is a novel adipokine, levels of which increase in obesity and is adipogenic; properties common to that of leptin. Thus, leptin may modulate visfatin production in adipose tissue. We investigated t...

ea0019p131 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Identification of nesfatin-1/NUCB2 as a novel depot-specific adipokine in human and murine adipose tissue: aletered levels in obesity and food deprivation

Ramanjaneya Manjunath , Chen Jing , Brown James , Patel Suketu , Tan Bee , Randeva Harpal

NESFATIN-1 is a recently identified hypothalamic satiety molecule derived from its precursor protein, NEFA/nucleobindin2 (NUCB2). Although the hypothalamus is considered the cornerstone for maintenance of energy homeostasis, adipose tissue plays an important role in the integration of metabolic activity and energy balance; communicating with peripheral organs and the brain via secreted proteins, termed adipokines. Many hypothalamic satiety regulatory peptides have been describ...

ea0019p146 | Diabetes, Metabolism and Cardiovascular | SFEBES2009

Metformin decreases angiogenesis via ERK1/2/ERK5 pathways by increasing the anti-angiogenic adipokine thrombospondin-1

Tan Bee , Kumar S Prashanth , Chen Jing , Heutling Dennis , Mitchell Dan , Lehnert Hendrik , Randeva Harpal

Aims: Polycystic ovary syndrome (PCOS) is associated with insulin resistance, obesity and cardiovascular complications. Thrombospondin-1 (TSP-1) is a novel anti-angiogenic adipokine highly expressed in obese, insulin-resistant subjects. We sought to assess TSP-1 levels in adipose (AT) from PCOS women and matched controls. The effects of metformin treatment on circulating TSP-1 levels in PCOS subjects; effects of serum from normal and PCOS women on in vitro migration and...